The vascular endothelial (VE)-cadherin regulating endothelial intercellular permeability were decreased in AMD rats, and treatment of ASA or CZTL (low-dose and medium-dose) could significantly increase the VE-cadherin to normal levels (p < 0.05) (Figure 4C). Here, CDH17 is linked to age-related macular degeneration.